BIOGEN for BIOGEN
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
1) Support domestic and international tax policies which protect and incentivize US-based research and manufacturing jobs; 2) Support maintaining the orphan drug tax credit; and 3) Support maintaining and making permanent the Research & Development tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND New | Chief of Staff, Rep. Linda Sanchez (CA-38) |
| ADAM GLUCK | Staff, Senate HELP Committee |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Trade (domestic/foreign) TRD
1) Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans-Pacific Partnership (TPP) trade agreement; and 2) Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the US-EU (TTIP) trade agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND New | Chief of Staff, Rep. Linda Sanchez (CA-38) |
| ADAM GLUCK | Staff, Senate HELP Committee |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Copyright/Patent/Trademark CPT
Patent legislation H.R. 3309 and S. 1720 promoting appropriate rules for discovery in patent cases for both drugs and biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GLUCK | Staff, Senate HELP Committee |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Health Issues HCR
1) Support 340B anti-fraud and program integrity policies; 2) Support policies to improve National Newborn Screening Program, including H.R. 1281 and S. 1417; and 3) ACA implementation oversight to protect patient access to medical specialists in new health care insurance exchanges.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM BRAND New | Chief of Staff, Rep. Linda Sanchez (CA-38) |
| ADAM GLUCK | Staff, Senate HELP Committee |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Medicare/Medicaid MMM
1) Opposition to rebates or price controls in the Medicare Part D program; and 2) Opposition to changes to the Medicare Part B reimbursement system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GLUCK | Staff, Senate HELP Committee |
| KATHLEEN TREGONING | Staff, House Committee on Ways & Means |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.